ProfileGDS4718 / 228709_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 22% 72% 35% 39% 36% 53% 31% 36% 30% 37% 44% 37% 34% 46% 35% 46% 25% 53% 34% 38% 43% 41% 40% 36% 51% 51% 39% 43% 40% 38% 51% 25% 25% 40% 55% 39% 34% 37% 78% 27% 43% 43% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8151236
GSM549102patient 115, normal, homogenized [OPG study]4.2382422
GSM549104patient 119, normal, homogenized [OPG study]7.1380572
GSM549108patient 138, normal, homogenized [OPG study]4.7913535
GSM549119patient 077, normal, homogenized [OPG study]4.9431339
GSM549133patient 032, cancer, homogenized [OPG study]4.7558936
GSM549139patient 042, cancer, homogenized [OPG study]5.6751153
GSM549099patient 107, normal, homogenized [OPG study]4.6154931
GSM549109patient 139, normal, homogenized [OPG study]4.846536
GSM549110patient 046, normal, homogenized [OPG study]4.541630
GSM549114patient 063, normal, homogenized [OPG study]4.7883737
GSM549122patient 082, normal, homogenized [OPG study]5.1811344
GSM549134patient 033, cancer, homogenized [OPG study]4.8356237
GSM549136patient 036, cancer, homogenized [OPG study]4.6395434
GSM549140patient 044, cancer, homogenized [OPG study]5.2558646
GSM549111patient 047, normal, homogenized [OPG study]4.7484235
GSM549113patient 057, normal, homogenized [OPG study]5.2547946
GSM549132patient 031, cancer, homogenized [OPG study]4.3375125
GSM549137patient 038, cancer, homogenized [OPG study]5.6510253
GSM549142patient 047, cancer, homogenized [OPG study]4.8546134
GSM549100patient 110, normal, homogenized [OPG study]4.9202838
GSM549107patient 135, normal, homogenized [OPG study]5.1173543
GSM549115patient 068, normal, homogenized [OPG study]4.9811641
GSM549116patient 072, normal, homogenized [OPG study]4.9523440
GSM549120patient 078, normal, homogenized [OPG study]4.82136
GSM549131patient 030, cancer, homogenized [OPG study]5.5003551
GSM549118patient 074, normal, homogenized [OPG study]5.552251
GSM549129patient 027, cancer, homogenized [OPG study]4.9810839
GSM549123patient 088, normal, homogenized [OPG study]5.1061943
GSM549124patient 006, cancer, homogenized [OPG study]5.0466740
GSM549126patient 015, cancer, homogenized [OPG study]4.8683938
GSM549128patient 025, cancer, homogenized [OPG study]5.5433651
GSM549103patient 117, normal, homogenized [OPG study]4.3699925
GSM549117patient 073, normal, homogenized [OPG study]4.3207225
GSM549138patient 041, cancer, homogenized [OPG study]4.984740
GSM549141patient 045, cancer, homogenized [OPG study]5.8046555
GSM549130patient 028, cancer, homogenized [OPG study]4.9451139
GSM549101patient 111, normal, homogenized [OPG study]4.7236134
GSM549105patient 128, normal, homogenized [OPG study]4.8677837
GSM549106patient 134, normal, homogenized [OPG study]7.7512278
GSM549112patient 048, normal, homogenized [OPG study]4.3966527
GSM549125patient 011, cancer, homogenized [OPG study]5.1658743
GSM549127patient 024, cancer, homogenized [OPG study]5.1616343
GSM549135patient 035, cancer, homogenized [OPG study]4.5220231